Infertility Solutions P. C.'s most recent IVF pregnancy data

(data compiled 2/16/2006)

We participate in national reporting of IVF data as administered by the Center for Disease Control (CDC) and the American Society of Reproductive Medicine's Society for Advanced Reproductive Technologies (SART). This nationally collected database can be reviewed at www.cdc.gov/nccdphp/drh/art03/03nation.htm. One of the shortcomings of this data is that it may be up to two years old. This is because it is reported on an annual basis and the data has to wait for all babies to be born who were conceived in the prior calendar year. Much can change in a program in that time period including personnel, procedures and equipment.

Our laboratory was completely redesigned to take advantage of newly available state-of-the-art technologies at the beginning of 2003. We have also changed our approach to laboratory personnel to try to capture the advantages of both small and large programs by supplementing our embryology staff with ongoing outside embryologists. For example, Dr. Lynette Scott and Joe Sokoloski have served in this capacity,

The availability of the internet makes it possible to present more up-to-date information about our program. This information can be used with the CDC/SART data to make an informed decision about program selection. We present ongoing pregnancy results with information about the patients but with identifying details removed.

Summary data is expressed in terms of pregnancy rate per IVF embryo transfer. Most of the time embryos are produced during an IVF cycle, but the problem is to get them to implant and become babies. Three types pregnancies are highlighted- biochemical (positive pregnancy test), clinical (tissue or ultrasound evidence of pregnancy including tubal pregnancies), and ongoing/delivered (the pregnancies delivered or with a high probability of delivering). The summary data is for women under age 35, because less patient selection takes place in this age category. Our program does not reject informed patients on the basis of age or decreased ovarian reserve (elevated FSH levels). This may adversely effect our pregnancy rates compared to programs which do select patients, but we have had many wonderful pregnancies in patients rejected by other programs.

Time period: Embryo tranfer between January 1,2005 through February 16, 2006

(This data contains all fresh IVF cases which either had transfers in 2005 or started meds in 2005)

Age.................Problem.............................Outcome

24.......................ovarian dysfunction........................ongoing pregnancy

26.......................endometriosis.................................ongoing pregnancy

26.......................PCO and male factor.....................clinical pregnancy

26.......................tubal factor.....................................ongoing pregnancy

28.......................tubal factor

28.......................male factor

28.......................PCO and male factor.....................ongoing pregnancy

29.......................male factor

29.......................PCO..............................................ongoing pregnancy

29........................male factor...................................ongoing pregnancy

29.......................decreased ovarian reserve

29.......................male factor.....................................ongoing pregnancy

29.......................endometriosis and adhesions.........clincal pregnancy

30.......................endometriosis................................biochemical pregnancy

30.......................PCO and tubal factor

30.......................tubal factor.....................................clinical pregnancy

30.......................tubal factor

30.......................decreased ovarian reserve..............clinical pregnancy

30.......................male factor

30.......................tubal factor....................................ongoing pregnancy

31.......................endometriosis and tubal factor.......biochemical pregnancy

31.......................PCO and male factor.....................ongoing pregnancy

31.......................male factor and PCO

31.......................male and tubal factor......................ongoing pregnancy

31.......................decreased ovarian reserve

31.......................male factor and PCO.....................clinical pregnancy

31.......................tubal

31.......................PCO...............................................biochemical pregnancy

32.......................other..............................................clinical pregnancy

33.......................unexplained...................................biochemical pregnancy

33.......................PCO..............................................biochemical pregnancy

33.......................unexplained...................................clinical pregnancy

34.......................tubal factor.....................................ongoing pregnancy

34.......................male and tubal factor, endometriosis....clinical pregnancy

34.......................tubal factor.....................................biochemical pregnancy

34.......................unexplained....................................ongoing pregnancy

34.......................tubal and uterine factor...................biochemical pregnancy

35.......................decreased ovarian reserve, male factor...biochemical pregnancy

35.......................male factor and ovarian reserve......biochemical pregnancy

35.......................unexplained....................................ongoing pregnancy

35.......................endometriosis and tubal factor.......clinical pregnancy

35.......................male factor and PCO......................ongoing pregnancy

35.......................tubal factor

35........................PCO and male factor.....................clinical pregnancy

35.......................male factor

35.......................unexplained.....................................ongoing pregnancy

35........................PCO...............................................ongoing pregnancy

35.......................male and uterine factor....................ongoing pregnancy

36.......................male factor......................................biochemical pregnancy

36.......................tubal and male factor.......................biochemical pregnancy

37.......................male factor......................................clinical pregnancy

37.......................PCO and male factor.......................ongoing pregnancy

37.......................male factor

37........................PCO and tubal factor......................biochemical pregnancy

37........................tubal factor.....................................clinical pregnancy

37........................decreased ovarian reserve...............biochemical pregnancy

38.......................unexplained.....................................ongoing pregnancy

38.......................unexplained

38.......................male factor.......................................biochemical pregnancy

38.......................male and tubal factor

39.......................unexplained

39.......................male factor.......................................biochemical pregnancy

39.......................PCO and male factor

39.......................PCO and male factor........................ongoing pregnancy

40.......................male factor

41.......................male and tubal factor.........................biochemical pregnancy

41.......................endometriosis and tubal factor

41.......................PCO and male factor.......................ongoing pregnancy

42.......................endometriosis and tubal factor

42.......................decreased ovarian reserve................biochemical pregnancy

45.......................male factor and ovarian reserve

Summary data for fresh IVF (patients under age 35) for the year 2005 to date*:

Biochemical pregnancies/IVF transfers- 30/41 or 73.2%

Clinical pregnancies/IVF transfers- 22/41 or 53.7%

Ongoing or delivered pregnancies/IVF transfers- 13/41 or 31.7%

Summary data for fresh IVF (patients under age 43) for the year 2005 to date*:

Clinical pregnancies/IVF transfers- 38/75 or 50.7%

Ongoing or delivered pregnancies/IVF transfers- 24/75 or 32%

*If using donor eggs, the age of the donor is used.

Summary data for fresh IVF (patients under age 35) for the year 2004**:

Clinical pregnancies/IVF transfers- 15/35 or 42.9%

Delivered pregnancies/IVF transfers- 13/35 or 37.1%

Summary data for fresh IVF (patients under age 35) for the year 2003**:

Clinical pregnancies/IVF transfers- 13/25 or 52%

Delivered pregnancies/IVF transfers- 9/25 or 36%

**Data in the above format is available by request

HOME | CONTENTS | CONTACT US